Which feature most reliably distinguishes unstable angina from NSTEMI in a patient presenting with acute coronary syndrome?

Explanation

## Unstable Angina vs NSTEMI: The Biomarker Distinction ### Definition and Pathology **Key Point:** Unstable angina is defined as acute coronary syndrome with ischemic symptoms and ECG changes (or risk factors) but **without myocardial necrosis**, as evidenced by the **absence of elevated cardiac biomarkers**. **High-Yield:** The 2023 ESC guidelines and ACC/AHA consensus define unstable angina specifically by the absence of troponin elevation in the setting of ACS features. ### Biomarker Kinetics in ACS | Biomarker | NSTEMI | Unstable Angina | |-----------|--------|------------------| | Troponin I/T | Elevated (>99th percentile) | Normal | | CKMB | Elevated | Normal | | Myoglobin | May be elevated | Normal | | Timing | Rises 2–4 hours, peaks 24–48 hours | Remains normal | **Clinical Pearl:** Serial troponin measurements (at 0, 3, and 6 hours) are essential in the emergency department. If troponin remains normal with appropriate clinical presentation and ECG changes, the diagnosis is unstable angina. A single elevated troponin confirms NSTEMI. ### Why Unstable Angina is Rare in Modern Practice With high-sensitivity troponin assays now standard, many cases previously labeled "unstable angina" are reclassified as NSTEMI due to detection of minimal myocardial necrosis. True unstable angina (negative biomarkers) is increasingly uncommon in contemporary practice. **Mnemonic:** **UA = Ischemia without Infarction** — the absence of biomarker elevation is the defining feature that separates unstable angina from NSTEMI in the ACS spectrum. [cite:Harrison 21e Ch 297]